Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo
- PMID: 8655997
- DOI: 10.1093/infdis/174.1.209
Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo
Abstract
The aim of this study was to investigate the extent of lysis mediated by cytotoxic T lymphocytes (CTL) directed against human immunodeficiency virus (HIV) type 1 gag protein and envelope glycoprotein in peripheral blood mononuclear cells (PBMC) from HIV-1-infected subjects and to compare it with nonspecific envelope glycoprotein-directed cytotoxicity involving CD4 T cells. Most seropositive subjects exhibited antigen-specific cytotoxicity directed at one or both viral antigens in unstimulated or in vitro-stimulated PBMC (or both) mediated by CD8 T cells. In addition, all donors, including seronegative control persons, exhibited nonspecific calcium-independent cytotoxicity involving CD4 T cells and envelope glycoprotein-expressing cells. No calcium-dependent, antigen-specific CD4 T cell-mediated cytolysis was detected. In seropositive subjects, the vigor of nonspecific cytotoxicity was comparable to lysis by antigen-specific CD8 CTL and suggests that it may contribute to lysis of HIV-infected cells in vitro and in vivo.
Similar articles
-
Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.J Exp Med. 1993 Feb 1;177(2):249-56. doi: 10.1084/jem.177.2.249. J Exp Med. 1993. PMID: 8093890 Free PMC article.
-
Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.J Exp Med. 1992 Dec 1;176(6):1531-42. doi: 10.1084/jem.176.6.1531. J Exp Med. 1992. PMID: 1460417 Free PMC article. Clinical Trial.
-
Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells.Immunol Lett. 1998 Dec;64(2-3):71-7. doi: 10.1016/s0165-2478(98)00084-4. Immunol Lett. 1998. PMID: 9870657
-
Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.Cell Mol Biol (Noisy-le-grand). 1994;40 Suppl 1:45-8. Cell Mol Biol (Noisy-le-grand). 1994. PMID: 7950861 Review.
-
Clonal analysis of T-cell responses to the HIV-1 envelope proteins in AIDS vaccine recipients.AIDS Res Hum Retroviruses. 1992 Aug;8(8):1349-52. doi: 10.1089/aid.1992.8.1349. AIDS Res Hum Retroviruses. 1992. PMID: 1361352 Review.
Cited by
-
Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones.J Virol. 2001 Oct;75(20):9771-9. doi: 10.1128/JVI.75.20.9771-9779.2001. J Virol. 2001. PMID: 11559810 Free PMC article.
-
Cytolytic CD4(+) T cells in viral immunity.Expert Rev Vaccines. 2010 Dec;9(12):1453-63. doi: 10.1586/erv.10.132. Expert Rev Vaccines. 2010. PMID: 21105780 Free PMC article. Review.
-
High major histocompatibility complex-unrestricted lysis of simian immunodeficiency virus envelope-expressing cells predisposes macaques to rapid AIDS progression.J Virol. 1999 May;73(5):3692-701. doi: 10.1128/JVI.73.5.3692-3701.1999. J Virol. 1999. PMID: 10196261 Free PMC article.
-
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13120-4. doi: 10.1073/pnas.95.22.13120. Proc Natl Acad Sci U S A. 1998. PMID: 9789051 Free PMC article.
-
Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51.Infect Immun. 2001 Sep;69(9):5502-8. doi: 10.1128/IAI.69.9.5502-5508.2001. Infect Immun. 2001. PMID: 11500423 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
